Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

New Drug Combo Slashes Bad Cholesterol by Nearly 50%

Daniel Kim Views  

Shutterstock
Shutterstock

A recent study published in The Lancet reveals that combining the new drug Obicetrapib and the existing medication Ezetimibe may effectively lower cholesterol levels in patients with high LDL despite statins.

Low-density lipoprotein (LDL), commonly known as “bad cholesterol,” is a key risk factor for various vascular conditions, including cardiovascular disease.

The American Heart Association (AHA) recommends keeping LDL levels below 100 mg/dL for low-risk individuals and under 70 mg/dL for high-risk individuals.

Statins, which inhibit the body’s cholesterol production, are widely prescribed and proven to help prevent cardiovascular disease. However, some patients continue to have elevated LDL levels even with statin therapy.

To evaluate the effectiveness of the new treatment, researchers enrolled 407 participants with an average age of 68. All had LDL levels above 70 mg/dL despite already being on cholesterol-lowering medication.

Participants were assigned to one of four treatment groups: one received a placebo, another received the combination of Obicetrapib and Ezetimibe, and the remaining two groups received each drug individually.

Throughout the study, all participants continued their regular cholesterol treatments.

After roughly three months, the group receiving the Obicetrapib and Ezetimibe combination showed a nearly 49% reduction in LDL levels.

Researchers emphasized that these results are auspicious for patients whose cholesterol remains uncontrolled despite standard medication.

The study concluded that combining Obicetrapib and Ezetimibe could be a highly effective option for managing LDL cholesterol in patients who do not respond sufficiently to existing therapies.

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[LIFESTYLE] Latest Stories

  • Why Your Eyelid Keeps Twitching—and When to Worry
  • Silent Spreaders: How Measles Can Infect Before Symptoms Appear
  • Eat More Eggplant—It’s Good for Your Blood and Your Heart
  • Want to Burn More Fat? Try a 30-Second Cold Shower, Experts Say
  • Bats, Fruit, and a Deadly Virus—Why Korea’s Health Officials Are on High Alert
  • Why You Crave Junk Food When You’re Sad—And What to Eat Instead

You May Also Like

  • 1
    Trump Claims Epstein 'Stole' Young Women from Mar-a-Lago Spa

    LATEST 

  • 2
    Say Hello to Your New Beauty Buddy: AI-Powered Kiosks Hit GS25 Stores!

    LATEST 

  • 3
    New Task Force Takes Aim at Stock Manipulators: A Game Changer for Investors!

    LATEST 

  • 4
    COP30 Chaos: Will Brazil's Soaring Hotel Prices Keep Poor Nations Out of Climate Talks?

    LATEST 

  • 5
    Is Tesla Behind LG Energy's Massive Battery Supply Contract?

    LATEST 

Popular Now

  • 1
    Taiwan's President Delays Trip to the Americas Amid Typhoon Chaos

    LATEST 

  • 2
    Hydroleap Secures $4.75 Million to Revolutionize Water Treatment in Asia!

    LATEST 

  • 3
    Enhypen's New Single 'Yoi' Soars to the Top, Selling Over 300,000 Copies on Day One!

    LATEST 

  • 4
    Chanyeol of EXO Set to Drop Solo Album This August – Here’s What We Know!

    LATEST 

  • 5
    Caught Between Borders: Texas Man's Harrowing Eight-Day Detention

    LATEST 

Must-Reads

  • 1
    Trump Claims Epstein 'Stole' Young Women from Mar-a-Lago Spa

    LATEST 

  • 2
    Say Hello to Your New Beauty Buddy: AI-Powered Kiosks Hit GS25 Stores!

    LATEST 

  • 3
    New Task Force Takes Aim at Stock Manipulators: A Game Changer for Investors!

    LATEST 

  • 4
    COP30 Chaos: Will Brazil's Soaring Hotel Prices Keep Poor Nations Out of Climate Talks?

    LATEST 

  • 5
    Is Tesla Behind LG Energy's Massive Battery Supply Contract?

    LATEST 

Popular Now

  • 1
    Taiwan's President Delays Trip to the Americas Amid Typhoon Chaos

    LATEST 

  • 2
    Hydroleap Secures $4.75 Million to Revolutionize Water Treatment in Asia!

    LATEST 

  • 3
    Enhypen's New Single 'Yoi' Soars to the Top, Selling Over 300,000 Copies on Day One!

    LATEST 

  • 4
    Chanyeol of EXO Set to Drop Solo Album This August – Here’s What We Know!

    LATEST 

  • 5
    Caught Between Borders: Texas Man's Harrowing Eight-Day Detention

    LATEST 

Share it on...